Nilo Saúde is a technology company.
Inteligência Artificial e automações para você maximizar os resultados financeiros e a eficiência da sua instituição de saúde.
Nilo Saúde has raised $13.0M across 2 funding rounds.
Nilo Saúde has raised $13.0M in total across 2 funding rounds.
Nilo Saúde has raised $13.0M in total across 2 funding rounds.
Nilo Saúde's investors include Accel, Flourish Ventures, Romero Rodrigues, Iporanga Ventures, Upload Ventures, Valor Capital Group, Flavio Dias, Ian McNish, Paulo Piccini, Atman Capital, Broadhaven Capital Partners, Global Founders Capital.
Nilo Saúde is a Brazilian healthtech company founded in 2020 that builds a SaaS platform for patient relationship management and care delivery, integrating software with care teams to enable healthcare businesses to provide personalized, continuous patient journeys.[1][2][3] Operating in the B2B segment, it serves health insurers, operators, autogestões, brokers, hospitals, and clinics—managing over 6 million lives—by centralizing patient data, boosting engagement via omni-channel communication, and delivering actionable insights to cut costs and improve outcomes.[1][2][4] The platform combines automation, telemedicine, clinical analytics, and human care support, positioning Nilo as the first such integrated solution in Brazil, with strong growth fueled by a $10M Series A in 2022 from investors like GFC, SoftBank Latin America Fund, Tau Ventures, MAYA Capital, and Canary Ventures.[3][5]
Nilo Saúde was founded in 2020 in São Paulo, Brazil, by Co-Founder and CEO Victor Marcondes, Isadora Kimura, and Rodrigo Luiz Grossi.[2][3] Victor, building his second company, teamed up with his co-founders after shared personal experiences navigating Brazil's complex healthcare system during family illnesses, highlighting gaps in patient-centric care.[2] The idea emerged from these challenges in a market serving over 212 million people, leading to the creation of Brazil's first SaaS health management platform that digitizes and simplifies care coordination.[1][2] Early traction came from B2B focus on insurers and clinics, culminating in the $10M Series A in January 2022 to enhance analytics and automation.[5]
Nilo Saúde rides the LatAm healthtech wave, capitalizing on Brazil's enormous emerging healthcare market amid rising demand for digital transformation post-pandemic, where inefficiencies in patient navigation plague 212+ million people.[2] Timing aligns with surging telemedicine adoption and insurer digitization, amplified by market forces like cost pressures on operators and regulatory pushes for integrated care in a fragmented system.[1][5] By pioneering SaaS for continuous, patient-focused journeys, Nilo influences the ecosystem by setting standards for B2B platforms that blend tech with human care, enabling scalability across Latin America and fostering efficiencies for clinics and insurers.[2][3]
Nilo Saúde is primed for hypergrowth in Brazil's vast market—expanding from 6M+ lives with existing clients—while eyeing LatAm neighbors through platform enhancements in analytics and automation.[2][5] Trends like AI personalization, omni-channel health engagement, and regional insurer consolidation will propel it, potentially evolving into a dominant player influencing care standards across emerging markets. As the first-mover in integrated health SaaS, Nilo's patient-centric northstar positions it to transform fragmented systems into efficient, relationship-driven ecosystems, building on its strong VC backing and proven traction.[2][3]
Nilo Saúde has raised $13.0M across 2 funding rounds. Most recently, it raised $11.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $11.0M Series A | Accel, Flourish Ventures, Romero Rodrigues, Iporanga Ventures, Upload Ventures, Valor Capital Group, Flavio Dias, Ian McNish, Paulo Piccini | |
| Apr 1, 2020 | $2.0M Seed | Accel, Atman Capital, Broadhaven Capital Partners, Global Founders Capital, Norte Ventures, Quona Capital, Valor Capital Group, Ariel Lambrecht, Justin Mateen |